ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cutera® Celebrates 25 Years of Excellence in Innovation

Industry leader honors legacy of revolutionary and groundbreaking first-to-market products

CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, is honored to announce that this year marks the monumental 25th anniversary for the company as an industry leader and innovator.

Since the company’s inception in 1998, Cutera has developed pioneering products that have transformed the market landscape, setting the bar with the coveted high-powered Nd: YAG with contact cooling for permanent hair removal, to the first radiofrequency-based device for lipolysis. The company proves to be a force in non-invasive solutions through product lines like truBody, offering the fastest body and muscle sculpting treatments on the market, with truSculptand truFlex™.

Cutera continues to establish a long legacy of imagination and engineering, developing novel technologies that have positively impacted practitioners and their patients worldwide. Their latest being the first-to-market 1726 nm laser, AviClear™, which received FDA-clearance in March of 2022 for the treatment of mild, moderate, and severe acne. Since its launch, AviClear has amassed multiple accolades including being named the “Best Laser Acne Treatment” by NewBeauty Magazine in April 2023.

“We are thrilled to be celebrating 25 years of Cutera and remain dedicated to upholding our legacy of ingenuity with energy-based devices that have transformed medical and aesthetic practices globally," said Sheila A. Hopkins, Interim Chief Executive Officer, Cutera, Inc. “Our mission is built upon our commitment to deliver effective clinical outcomes to patients and providers with products like excel V+, xeo, and many others, while continually enhancing our service and support.”

“Cutera’s devices have been a staple in our practice for over a decade,” said board-certified dermatologist Ashish C. Bhatia, MD, FAAD. “I am proud to work alongside a company who values our clinical input and keeps striving to improve their technology. We are constantly impressed by their unique and creative approach to addressing challenging conditions, and their latest device, AviClear, is no exception. We have been overwhelmed by the results our AviClear patients have seen and look forward to being able to change even more lives with this extraordinary treatment.”

Cutera looks toward the next 25 years to not only develop additional technologies but to expand upon the value that it can add to aesthetic and dermatology practices. The company is furthering ways to partner with providers that include advancing accessibility and implementing modern business models.

To commemorate this exciting milestone, Cutera will be celebrating at the American Society for Laser Medicine and Surgery on April 14th in Phoenix, Arizona, joined by esteemed physician leaders and fellow industry professionals. Additional anniversary activities and customer events are slated for the remainder of 2023.

Further information on Cutera and its portfolio of products can be found at Cutera.com. Follow the 25 Year Anniversary on Instagram @cuterainc.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.